Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 32 n° 250

Posts Tagged ‘trasparency’

Dove è finita la corruzione?

Posted by fidest press agency su lunedì, 10 febbraio 2020

Roma martedì 11 febbraio ore 16 presso la sede dell’ Anac Via Marco Minghetti, 10 E’ stata al centro del dibattito politico e di diverse riforme susseguitesi negli ultimi anni. Eppure, da qualche tempo sembra suscitare meno attenzione, anche da parte dei media. Il rallentamento dell’Italia nella classifica del CPI e i moltissimi casi mappati quotidianamente da Transparency International Italia raccontano invece una storia diversa: la corruzione è ancora qui, è ancora tanta e merita tutta la nostra attenzione. Ne discutono Alfonso Bonafede, Ministro della Giustizia, Francesco Merloni, Presidente di ANAC e Virginio Carnevali, Presidente di Transparency International Italia.

Posted in Roma/about Rome, Spazio aperto/open space | Contrassegnato da tag: , , , | Leave a Comment »

Transparency: better access to documents and protection of whistleblowers needed in the EU

Posted by fidest press agency su domenica, 23 febbraio 2014

The widest possible public access to documents is needed to effectively allow citizens to comment on all aspects of EU activity, says a report adopted by the Civil Liberties Committee on Thursday. MEPs call on the Council to finally move forward with the revision of the regulation on access to documents and for a Transparency officer in each EU institution. They also urge for better protection of whistleblowers.
The Lisbon Treaty lays down the fundamental right of access to documents, MEPs stress, recalling that “any decision denying access to documents must be based on clearly and strictly defined legal exceptions, accompanied by reasoned and specific justification, allowing the citizen to understand the denial of access and to make effective use of the legal remedies available”.Citizens have a right to know how the decision-making process works, how their representatives act, hold them accountable and to know how public money is allocated and spent, stresses the report.The EU legislation on access to documents is still not being properly applied by the EU’s administration, says the committee, noting that the “exceptions of Regulation (EC) No 1049/2001 [on public access to documents] are being applied routinely rather than of exceptionally”. It calls on the institutions, bodies and agencies to strictly apply this regulation, taking full account of the body of case-law on this matter. MEPs express their disappointment with the fact that since December 2011, when Parliament adopted its first reading position on the revision of the regulation, “no progress has been made, since the Council and the Commission did not seem ready to embark on substantive negotiations”. They call on the Council to finally move forward with the revision and on both institutions to agree on a new instrument that provides significantly more transparency.The Civil Liberties Committee calls on all the institutions to evaluate and, where necessary, review their internal arrangements for reporting wrongdoing, and calls for the protection of whistleblowers. “In a healthy democracy citizens should not have to rely on whistleblowers in order to ensure transparency of their governments’ competences and activities”, it adds.
The Commission should table a proposal to protect whistleblowers “not only morally, but also financially in order to properly protect and support whistleblowers as part of the democratic system”, says the text.
MEPs recommend that each EU institution or body appoint from within its management structures a Transparency Officer, to be responsible for compliance and for improving practices. EU institutions should also put in place “public document registers” with clear and accessible structures and good search functionality, they add.
International agreements, such as the envisaged Transatlantic Trade and Investment Partnership (TTIP) with the US, have binding effects and impact on EU laws. Documents related to them should therefore be public in principle, says the committee.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

Awarded at BioPharma Asia Industry Awards 2013

Posted by fidest press agency su martedì, 26 marzo 2013

Raleigh, North Carolina, March 25, 2013 /PRNewswire/ — PRA, a leading clinical research organization, today announced it was voted “Best CRO” for the 3rd annual BioPharma Asia Industry Awards 2013. The winner was announced March 19 at an awards dinner in Singapore.
Organized by Terrapinn, the awards honor and generate public recognition of the efforts, accomplishments and positive contributions of organizations and individuals in Asia’s biopharmaceutical industry. They identify and reward those who demonstrate an ability to succeed, continually set standards of excellence, and who will be the future of the biopharmaceutical industry. There are nine award categories: Best LSP Award; Best Contract Research Organization Award; Best Contract Manufacturing Organization Award; Most Innovative Asian Biotech Award; Asian Executive of the Year; Woman Executive of the Year; Best Manufacturing Solution Provider Award; Best Drug Pipeline Award; and Pharma Company of the Year.
PRA is transforming clinical trials through our people, innovation and transparency. PRA provides personalized service customized to the unique requirements of each study. We support our global reach and innovative approach through flexible and reliable service, delivered by skilled employees dedicated to ensuring that sponsors achieve their long-term goals. We serve our clients across all phases of pharmaceutical and biotech drug development by combining therapeutic and operational expertise with local knowledge. Offering services in 80+ countries and serving sponsors for 35+ years, we have amassed a level of expertise that has enabled us to work on a variety of compounds, ranging from niche treatments and therapies to blockbuster drugs. But at PRA, we are looking to the future, not the past. Our increasingly forward-thinking approach to transforming the clinical trial landscape will continue to make a difference to healthcare patients around the world.

Posted in Economia/Economy/finance/business/technology, Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »